Evidence map›Paper›PMID 33526450›Full record

ArticleMolecular and cellular biology2021

Scaffolding Protein IQGAP1 Is Dispensable, but Its Overexpression Promotes Hepatocellular Carcinoma via YAP1 Signaling.

Evan R Delgado, Hanna L Erickson, Junyan Tao, Satdarshan P Monga, Andrew W Duncan, Sayeepriyadarshini Anakk

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Inhibition of induced-hepatic cancerFrontiers in oncology · 2022
    Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Evan R Delgado *Department of Pathology, McGowan Institute for Regenerative Medicine, Pittsburgh Liver Research Center, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.ORCID 0000-0003-2706-0946
Hanna L Erickson *Department of Molecular and Integrative Physiology, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.ORCID 0000-0002-4421-2908
Junyan TaoDepartment of Pathology, McGowan Institute for Regenerative Medicine, Pittsburgh Liver Research Center, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Satdarshan P MongaDepartment of Pathology, McGowan Institute for Regenerative Medicine, Pittsburgh Liver Research Center, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.ORCID 0000-0002-8437-3378
Andrew W DuncanDepartment of Pathology, McGowan Institute for Regenerative Medicine, Pittsburgh Liver Research Center, University of Pittsburgh, Pittsburgh, Pennsylvania, USA duncana@pitt.edu anakk@illinois.edu.ORCID 0000-0003-4962-4191
Sayeepriyadarshini AnakkDepartment of Molecular and Integrative Physiology, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA duncana@pitt.edu anakk@illinois.edu.ORCID 0000-0003-2819-695X
University of Pittsburgh · USUniversity of Illinois Urbana-Champaign · US

Funding

Pittsburgh Liver Research CenterP30DK120531 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Satdarshan Singh Monga · 2019 to 2026
$10.9M
Mechanisms of Polyploidy and Aneuploidy in the LiverR01DK103645 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DUNCAN, ANDREW W · 2014 to 2023
$4.1M
Understanding Mechanisms that Regulate Liver Growth and FunctionR01DK113080 · NIDDK · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI Sayeepriyadarshini Anakk · 2017 to 2026
$3.3M
Targeting tumor metabolism and immune environment via beta-catenin: Towards precision medicine in HCCR01CA251155 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI LUJAMBIO, AMAIA, MONGA, SATDARSHAN SINGH · 2020 to 2024
$3.1M
Investigating Multifactorial Beta-catenin Activation in Hepatocellular CancersR01CA250227 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Xin Chen, Satdarshan Singh Monga · 2021 to 2026
$3.0M
Yap and beta-catenin interactions in liver: Implications in PathophysiologyR01CA204586 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI CHEN, XIN, MONGA, SATDARSHAN SINGH · 2016 to 2020
$2.1M
Bile Acid-Mediated IQGAP1 Regulation Drives Hepatic TumorigenesisF30CA206495 · NCI · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI ERICKSON, HANNA · 2018 to 2021
$190k
NCI NIH HHS F30 CA206495NCI NIH HHS R01 CA204586NCI NIH HHS R01 CA250227NCI NIH HHS R01 CA251155NIDDK NIH HHS P30 DK120531NIDDK NIH HHS R01 DK103645NIDDK NIH HHS R01 DK113080
6 · The paper itself

Abstract

IQ motif-containing GTPase-activating protein 1 (IQGAP1) is a ubiquitously expressed scaffolding protein that is overexpressed in a number of cancers, including liver cancer, and is associated with protumorigenic processes, such as cell proliferation, motility, and adhesion. IQGAP1 can integrate multiple signaling pathways and could be an effective antitumor target. Therefore, we examined the role of IQGAP1 in tumor initiation and promotion during liver carcinogenesis. We found that ectopic overexpression of IQGAP1 in the liver is not sufficient to initiate tumorigenesis. Moreover, we report that the tumor burden and cell proliferation in the diethylnitrosamine-induced liver carcinogenesis model in

Indexed as

Adaptor Proteins, Signal TransducingAnimalsCarcinogenesisCarcinoma, HepatocellularCell Cycle ProteinsCell MovementCell ProliferationCell Transformation, NeoplasticGene Expression Regulation, NeoplasticLiverLiver NeoplasmsMiceMice, Knockoutras GTPase-Activating ProteinsYAP-Signaling ProteinsAdaptor Proteins, Signal TransducingCell Cycle ProteinsIQ motif containing GTPase activating protein 1ras GTPase-Activating ProteinsYap1 protein, mouseYAP-Signaling ProteinsIQGAP1liver cancerMETscaffold proteinYAP

Identifiers

PMID33526450
PMCPMC8088129
OpenAlexW3127249977

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.